Loading...

PE/Cyanine7 anti-mouse CD8a Antibody PE/Cyanine7 anti-mouse CD8a Antibody

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-67_PECyanine7_CD8a_Antibody_1_071124
C57BL/6 mouse splenocytes were stained with anti-mouse CD3ε (clone 145-2C11) FITC and anti-mouse CD8a (clone 53-6.7) PE/Cyanine7 (left) or rat IgG2a, κ PE/Cyanine7 isotype control (right).
  • 53-67_PECyanine7_CD8a_Antibody_1_071124
    C57BL/6 mouse splenocytes were stained with anti-mouse CD3ε (clone 145-2C11) FITC and anti-mouse CD8a (clone 53-6.7) PE/Cyanine7 (left) or rat IgG2a, κ PE/Cyanine7 isotype control (right).
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
100722 100 µg SEK1664
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100721 25 µg SEK572
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Vick SC, et al. 2021. J Immunol. 207:2598. PubMed
  2. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  3. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  4. Schnell A, et al. 2021. Cell. 184:6281. PubMed
  5. Fu A, et al. 2022. Cell. 185:1356. PubMed
  6. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  7. Guttman O, et al. 2022. J Cell Biol. 221: . PubMed
  8. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  9. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  10. Gao Y, et al. 2022. Cell Res. 32:1086. PubMed
  11. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  12. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  13. Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed
  14. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  15. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  16. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  17. Wang C, et al. 2023. Exp Mol Med. 55:347. PubMed
  18. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  19. Georgiev GI, et al. 2022. Cell Chem Biol. 29:811. PubMed
  20. Zhu Z, et al. 2022. Clin Cancer Res. 28:4820. PubMed
  21. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  22. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  23. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  24. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  25. Schönberger K, et al. 2023. Anal Chem. 95:4325. PubMed
  26. Li L, et al. 2023. iScience. 26:106095. PubMed
  27. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  28. Cheng K, et al. 2023. Small. 19:e2300125. PubMed
  29. Li G, et al. 2023. Cell Death Dis. 14:185. PubMed
  30. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  31. Wang Y, et al. 2023. Front Bioeng Biotechnol. 11:1128268. PubMed
  32. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  33. Sun R, et al. 2023. PLoS One. 18:e0282722. PubMed
  34. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  35. Jarick KJ, et al. 2018. Front Immunol. 9:1468. PubMed
  36. Seo JB, et al. 2019. Nat Metab. 1:86. PubMed
  37. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  38. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  39. Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed
  40. Denk D, et al. 2022. Immunity. 55:2059. PubMed
  41. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  42. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  43. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  44. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  45. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  46. Tello‐Lafoz M, et al. 2017. Sci Rep. . 10.1038/s41598-017-16370-w. PubMed
  47. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  48. Lechuga-Vieco AV, et al. 2020. Sci Adv. 6:eaba5345. PubMed
  49. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  50. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  51. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  52. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  53. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  54. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  55. Mei S, et al. 2022. Front Immunol. 13:911164. PubMed
  56. Ma F, et al. 2020. Cell Death Dis. 1.172222222. PubMed
  57. Baram T, et al. 2021. Cells. 10:. PubMed
  58. Leier A, et al. 2022. Mol Ther Nucleic Acids. 28:261. PubMed
  59. Andreas N, et al. 2021. Arthritis Res Ther. 23:222. PubMed
  60. Alotaibi F, et al. 2021. Front Immunol. 11:584937. PubMed
  61. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  62. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
  63. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  64. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  65. Wu FTH, et al. 2019. Br J Cancer. 120:196. PubMed
  66. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  67. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  68. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  69. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  70. Saito S, et al. 2020. Nutrients. 12:. PubMed
  71. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  72. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  73. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  74. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  75. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  76. Hung PJ, et al. 2018. Mol Cell. 71:332. PubMed
  77. Neubert K, et al. 2014. J Immunol. 192:5830. PubMed
  78. Sakthivel P, et al. 2014. PLoS One. 9:100970. PubMed
  79. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  80. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  81. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  82. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  83. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  84. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  85. Guo HF, et al. 2021. Commun Biol. 4:482. PubMed
  86. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  87. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  88. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  89. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  90. Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
  91. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  92. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  93. Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed
  94. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  95. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  96. Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed
  97. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  98. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  99. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  100. Wei M, et al. 2014. Protein Eng Des Sel. 27:289. PubMed
  101. Collinson-Pautz M, et al. 2016. PLoS One. 11:e0164547. PubMed
  102. Amor C, et al. 2020. Nature. 583:127. PubMed
  103. Dumas AA, et al. 2020. EMBO J. 39:e103790. PubMed
  104. Szafran BN, et al. 2021. Chemical Research in Toxicology. 34(6):1556-1571. PubMed
  105. Li J, et al. 2020. Cancer Discov. . PubMed
  106. Wei SC, et al. 2020. Cancer Discov. . PubMed
  107. Alsaleh G, et al. 2020. Elife. 9: . PubMed
  108. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  109. Daniel CJ, et al. 2022. Mol Cancer Res. 20:1151. PubMed
  110. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  111. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  112. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  113. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  114. Dar HY, et al. 2018. Sci Rep. 8:2503. PubMed
  115. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
  116. Li J, et al. 2020. Cancer Immunol Res. 0.529166667. PubMed
  117. Köchl R, et al. 2020. Elife. 9:00. PubMed
  118. Sullivan B, et al. 2015. PLoS Pathog. 11:1004588. PubMed
  119. Taniguchi H, et al. 2022. Cell Rep. 39:110814. PubMed
  120. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  121. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  122. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  123. Dar HY, et al. 2018. Bone Rep. 8:46. PubMed
  124. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  125. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  126. Li J, et al. 2018. Immunity. 49:178. PubMed
  127. Domingo–Gonzalez R, et al. 2020. eLife. 9:e56890.. PubMed
  128. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  129. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  130. Gong Y, et al. 2020. Cell Metabolism. 33(1):51-64.e9. PubMed
  131. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
  132. Pinho S, et al. 2022. Nat Cell Biol. 24:290. PubMed
  133. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  134. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  135. Reese B, et al. 2020. J Immunol. 205:3218. PubMed
  136. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  137. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  138. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  139. Sapra L, et al. 2021. Sci Rep. 11:1807. PubMed
  140. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  141. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  142. Yang Y, et al. 2022. Elife. 11:. PubMed
  143. Kim S, et al. 2021. Elife. 10:. PubMed
  144. Anger-Góra N, et al. 2021. Oncol Lett. 22:582. PubMed
  145. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  146. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  147. Pietronigro E, et al. 2019. Sci Rep. 9:12055. PubMed
  148. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  149. Abramowski P, et al. 2014. J Neuroimmunol. 274:111. PubMed
  150. Ariyoshi Y, et al. 2016. Gene Ther. 10.1038/gt.2016.7. PubMed
  151. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  152. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  153. Tan X, et al. 2021. Sci Adv. 7: . PubMed
  154. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  155. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  156. Lang V, et al. 2021. Elife. 10:. PubMed
  157. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  158. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  159. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  160. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  161. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  162. Yabas M, et al. 2016. PLoS One. 11: 0146774. PubMed
  163. Timilshina M, et al. 2017. PLoS One. 10.1371/journal.pone.0168942. PubMed
  164. Jandke A, et al. 2020. Nat Commun. 3.075694444. PubMed
  165. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  166. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  167. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  168. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  169. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
  170. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  171. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
  172. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  173. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  174. Nelson CE et al. 2019. Cell Rep. 28(12):3092-3104 . PubMed
  175. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  176. Niderla-Bielinska J, et al. 2021. Int J Mol Sci. :22. PubMed
  177. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  178. Itoga M, et al. 2015. PLoS One. 10: e0123210. PubMed
  179. Bhatt D, et al. 2021. J Exp Med. 218:. PubMed
  180. Wang D, et al. 2022. EMBO Rep. 23:e53691. PubMed
  181. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  182. Kojima H, et al. 2021. Scand J Immunol. 93:e13020. PubMed
  183. Emily A Thompson et al. 2019. Cell reports. 26(11):2859-2867 . PubMed
  184. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  185. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  186. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
  187. Ligon MM, et al. 2020. Mucosal Immunol. 1.172222222. PubMed
  188. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  189. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  190. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  191. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  192. Bell CR, et al. 2022. Nat Commun. 13:2063. PubMed
  193. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
  194. Silva DA, et al. 2019. Nature. 565:186. PubMed
  195. Lee YS, et al. 2019. Sci Adv. 5:eaaw4176. PubMed
  196. Abdelsamed HA, et al. 2020. Nat Immunol. 1.276388889. PubMed
  197. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  198. Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
  199. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  200. Rouse MD, et al. 2020. Front Microbiol. 11:414. PubMed
  201. Lopes N, et al. 2022. Elife. 11:. PubMed
  202. Tang S, et al. 2022. Virol J. 19:32. PubMed
  203. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  204. Fitzpatrick Z, et al. 2020. Nature. 587:472. PubMed
  205. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
  206. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  207. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  208. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  209. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  210. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  211. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  212. Wang X, et al. 2022. Elife. 11:. PubMed
  213. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  214. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  215. Ding Z, et al. 2017. Sci Rep. 10.1038/s41598-017-12488-z. PubMed
  216. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  217. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  218. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  219. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  220. Sheng J, et al. 2021. eLife. 10:00. PubMed
  221. Mykkänen O, et al. 2014. PLoS One. 9:114790. PubMed
  222. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  223. Goubet AG, et al. 2021. Cell Death Differ. 28:2276. PubMed
  224. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  225. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  226. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  227. Goc J, et al. 2021. Cell. 184:5015. PubMed
  228. Plaza-Sirvent C, et al. 2021. Front Immunol. 12:705436. PubMed
  229. Fearon AE, et al. 2021. iScience. 24:103143. PubMed
  230. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  231. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  232. Kim SH, et al. 2020. Neoplasia. 1.3375. PubMed
  233. Reinke S, et al. 2020. Cell Reports. 30(8):2501-2511. PubMed
  234. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  235. Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
  236. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  237. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  238. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  239. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  240. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
  241. Vick SC, et al. 2021. J Immunol. 207:2598. PubMed
  242. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  243. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  244. Schnell A, et al. 2021. Cell. 184:6281. PubMed
  245. Fu A, et al. 2022. Cell. 185:1356. PubMed
  246. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  247. Guttman O, et al. 2022. J Cell Biol. 221: . PubMed
  248. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  249. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  250. Gao Y, et al. 2022. Cell Res. 32:1086. PubMed
  251. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  252. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  253. Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed
  254. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  255. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  256. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  257. Wang C, et al. 2023. Exp Mol Med. 55:347. PubMed
  258. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  259. Georgiev GI, et al. 2022. Cell Chem Biol. 29:811. PubMed
  260. Zhu Z, et al. 2022. Clin Cancer Res. 28:4820. PubMed
  261. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  262. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  263. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  264. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  265. Schönberger K, et al. 2023. Anal Chem. 95:4325. PubMed
  266. Li L, et al. 2023. iScience. 26:106095. PubMed
  267. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  268. Cheng K, et al. 2023. Small. 19:e2300125. PubMed
  269. Li G, et al. 2023. Cell Death Dis. 14:185. PubMed
  270. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  271. Wang Y, et al. 2023. Front Bioeng Biotechnol. 11:1128268. PubMed
  272. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  273. Sun R, et al. 2023. PLoS One. 18:e0282722. PubMed
  274. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  275. Jarick KJ, et al. 2018. Front Immunol. 9:1468. PubMed
  276. Seo JB, et al. 2019. Nat Metab. 1:86. PubMed
  277. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  278. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  279. Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed
  280. Denk D, et al. 2022. Immunity. 55:2059. PubMed
  281. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  282. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  283. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  284. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  285. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  286. Tello‐Lafoz M, et al. 2017. Sci Rep. . 10.1038/s41598-017-16370-w. PubMed
  287. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  288. Lechuga-Vieco AV, et al. 2020. Sci Adv. 6:eaba5345. PubMed
  289. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  290. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  291. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  292. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  293. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  294. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  295. Mei S, et al. 2022. Front Immunol. 13:911164. PubMed
  296. Ma F, et al. 2020. Cell Death Dis. 1.172222222. PubMed
  297. Baram T, et al. 2021. Cells. 10:. PubMed
  298. Leier A, et al. 2022. Mol Ther Nucleic Acids. 28:261. PubMed
  299. Andreas N, et al. 2021. Arthritis Res Ther. 23:222. PubMed
  300. Alotaibi F, et al. 2021. Front Immunol. 11:584937. PubMed
  301. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  302. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
  303. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  304. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  305. Wu FTH, et al. 2019. Br J Cancer. 120:196. PubMed
  306. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  307. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  308. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  309. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  310. Saito S, et al. 2020. Nutrients. 12:. PubMed
  311. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  312. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  313. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  314. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  315. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  316. Hung PJ, et al. 2018. Mol Cell. 71:332. PubMed
  317. Neubert K, et al. 2014. J Immunol. 192:5830. PubMed
  318. Sakthivel P, et al. 2014. PLoS One. 9:100970. PubMed
  319. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  320. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  321. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  322. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  323. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  324. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  325. Guo HF, et al. 2021. Commun Biol. 4:482. PubMed
  326. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  327. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  328. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  329. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  330. Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
  331. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  332. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  333. Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed
  334. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  335. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  336. Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed
  337. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  338. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  339. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  340. Wei M, et al. 2014. Protein Eng Des Sel. 27:289. PubMed
  341. Collinson-Pautz M, et al. 2016. PLoS One. 11:e0164547. PubMed
  342. Amor C, et al. 2020. Nature. 583:127. PubMed
  343. Dumas AA, et al. 2020. EMBO J. 39:e103790. PubMed
  344. Szafran BN, et al. 2021. Chemical Research in Toxicology. 34(6):1556-1571. PubMed
  345. Li J, et al. 2020. Cancer Discov. . PubMed
  346. Wei SC, et al. 2020. Cancer Discov. . PubMed
  347. Alsaleh G, et al. 2020. Elife. 9: . PubMed
  348. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  349. Daniel CJ, et al. 2022. Mol Cancer Res. 20:1151. PubMed
  350. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  351. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  352. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  353. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  354. Dar HY, et al. 2018. Sci Rep. 8:2503. PubMed
  355. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
  356. Li J, et al. 2020. Cancer Immunol Res. 0.529166667. PubMed
  357. Köchl R, et al. 2020. Elife. 9:00. PubMed
  358. Sullivan B, et al. 2015. PLoS Pathog. 11:1004588. PubMed
  359. Taniguchi H, et al. 2022. Cell Rep. 39:110814. PubMed
  360. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  361. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  362. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  363. Dar HY, et al. 2018. Bone Rep. 8:46. PubMed
  364. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  365. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  366. Li J, et al. 2018. Immunity. 49:178. PubMed
  367. Domingo–Gonzalez R, et al. 2020. eLife. 9:e56890.. PubMed
  368. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  369. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  370. Gong Y, et al. 2020. Cell Metabolism. 33(1):51-64.e9. PubMed
  371. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
  372. Pinho S, et al. 2022. Nat Cell Biol. 24:290. PubMed
  373. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  374. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  375. Reese B, et al. 2020. J Immunol. 205:3218. PubMed
  376. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  377. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  378. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  379. Sapra L, et al. 2021. Sci Rep. 11:1807. PubMed
  380. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  381. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  382. Yang Y, et al. 2022. Elife. 11:. PubMed
  383. Kim S, et al. 2021. Elife. 10:. PubMed
  384. Anger-Góra N, et al. 2021. Oncol Lett. 22:582. PubMed
  385. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  386. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  387. Pietronigro E, et al. 2019. Sci Rep. 9:12055. PubMed
  388. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  389. Abramowski P, et al. 2014. J Neuroimmunol. 274:111. PubMed
  390. Ariyoshi Y, et al. 2016. Gene Ther. 10.1038/gt.2016.7. PubMed
  391. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  392. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  393. Tan X, et al. 2021. Sci Adv. 7: . PubMed
  394. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  395. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  396. Lang V, et al. 2021. Elife. 10:. PubMed
  397. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  398. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  399. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  400. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  401. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  402. Yabas M, et al. 2016. PLoS One. 11: 0146774. PubMed
  403. Timilshina M, et al. 2017. PLoS One. 10.1371/journal.pone.0168942. PubMed
  404. Jandke A, et al. 2020. Nat Commun. 3.075694444. PubMed
  405. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  406. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  407. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  408. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  409. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
  410. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  411. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
  412. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  413. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  414. Nelson CE et al. 2019. Cell Rep. 28(12):3092-3104 . PubMed
  415. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  416. Niderla-Bielinska J, et al. 2021. Int J Mol Sci. :22. PubMed
  417. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  418. Itoga M, et al. 2015. PLoS One. 10: e0123210. PubMed
  419. Bhatt D, et al. 2021. J Exp Med. 218:. PubMed
  420. Wang D, et al. 2022. EMBO Rep. 23:e53691. PubMed
  421. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  422. Kojima H, et al. 2021. Scand J Immunol. 93:e13020. PubMed
  423. Emily A Thompson et al. 2019. Cell reports. 26(11):2859-2867 . PubMed
  424. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  425. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  426. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
  427. Ligon MM, et al. 2020. Mucosal Immunol. 1.172222222. PubMed
  428. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  429. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  430. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  431. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  432. Bell CR, et al. 2022. Nat Commun. 13:2063. PubMed
  433. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
  434. Silva DA, et al. 2019. Nature. 565:186. PubMed
  435. Lee YS, et al. 2019. Sci Adv. 5:eaaw4176. PubMed
  436. Abdelsamed HA, et al. 2020. Nat Immunol. 1.276388889. PubMed
  437. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  438. Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
  439. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  440. Rouse MD, et al. 2020. Front Microbiol. 11:414. PubMed
  441. Lopes N, et al. 2022. Elife. 11:. PubMed
  442. Tang S, et al. 2022. Virol J. 19:32. PubMed
  443. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  444. Fitzpatrick Z, et al. 2020. Nature. 587:472. PubMed
  445. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
  446. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  447. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  448. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  449. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  450. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  451. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  452. Wang X, et al. 2022. Elife. 11:. PubMed
  453. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  454. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  455. Ding Z, et al. 2017. Sci Rep. 10.1038/s41598-017-12488-z. PubMed
  456. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  457. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  458. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  459. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  460. Sheng J, et al. 2021. eLife. 10:00. PubMed
  461. Mykkänen O, et al. 2014. PLoS One. 9:114790. PubMed
  462. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  463. Goubet AG, et al. 2021. Cell Death Differ. 28:2276. PubMed
  464. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  465. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  466. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  467. Goc J, et al. 2021. Cell. 184:5015. PubMed
  468. Plaza-Sirvent C, et al. 2021. Front Immunol. 12:705436. PubMed
  469. Fearon AE, et al. 2021. iScience. 24:103143. PubMed
  470. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  471. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  472. Kim SH, et al. 2020. Neoplasia. 1.3375. PubMed
  473. Reinke S, et al. 2020. Cell Reports. 30(8):2501-2511. PubMed
  474. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  475. Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
  476. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  477. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  478. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  479. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  480. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
RRID
AB_312761 (BioLegend Cat. No. 100722)
AB_312760 (BioLegend Cat. No. 100721)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC,IHC
FITC anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC-F,IP
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC,3D IHC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC,IHC,SB
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC,IP,Depletion,Block
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F,FC,3D IHC
Spark Blue™ 574 anti-mouse CD8a Antibody 53-6.7 FC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Spark UV™ 387 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 515 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark Red™ 718 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
PE/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark PLUS UV395™ anti-mouse CD8a 53-6.7 FC
PerCP/Fire™ 780 anti-mouse CD8a 53-6.7 FC
Spark YG™ 581 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
Spark YG™ 593 anti-mouse CD8a (Flexi-Fluor™) Antibody 53-6.7 FC
StarBright UltraViolet 575 anti-mouse CD8a 53-6.7 FC
Spark PLUS V475™ anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 795 anti-mouse CD8a 53-6.7 FC
Go To Top Version: 2    Revision Date: 01-21-2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-67_PECyanine7_CD8a_Antibody_1_071124
C57BL/6 mouse splenocytes were stained with anti-mouse CD3ε (clone 145-2C11) FITC and anti-mouse CD8a (clone 53-6.7) PE/Cyanine7 (left) or rat IgG2a, κ PE/Cyanine7 isotype control (right).
  • 53-67_PECyanine7_CD8a_Antibody_1_071124
    C57BL/6 mouse splenocytes were stained with anti-mouse CD3ε (clone 145-2C11) FITC and anti-mouse CD8a (clone 53-6.7) PE/Cyanine7 (left) or rat IgG2a, κ PE/Cyanine7 isotype control (right).
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
100722 100 µg SEK1664
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100721 25 µg SEK572
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Vick SC, et al. 2021. J Immunol. 207:2598. PubMed
  2. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  3. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  4. Schnell A, et al. 2021. Cell. 184:6281. PubMed
  5. Fu A, et al. 2022. Cell. 185:1356. PubMed
  6. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  7. Guttman O, et al. 2022. J Cell Biol. 221: . PubMed
  8. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  9. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  10. Gao Y, et al. 2022. Cell Res. 32:1086. PubMed
  11. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  12. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  13. Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed
  14. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  15. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  16. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  17. Wang C, et al. 2023. Exp Mol Med. 55:347. PubMed
  18. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  19. Georgiev GI, et al. 2022. Cell Chem Biol. 29:811. PubMed
  20. Zhu Z, et al. 2022. Clin Cancer Res. 28:4820. PubMed
  21. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  22. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  23. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  24. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  25. Schönberger K, et al. 2023. Anal Chem. 95:4325. PubMed
  26. Li L, et al. 2023. iScience. 26:106095. PubMed
  27. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  28. Cheng K, et al. 2023. Small. 19:e2300125. PubMed
  29. Li G, et al. 2023. Cell Death Dis. 14:185. PubMed
  30. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  31. Wang Y, et al. 2023. Front Bioeng Biotechnol. 11:1128268. PubMed
  32. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  33. Sun R, et al. 2023. PLoS One. 18:e0282722. PubMed
  34. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  35. Jarick KJ, et al. 2018. Front Immunol. 9:1468. PubMed
  36. Seo JB, et al. 2019. Nat Metab. 1:86. PubMed
  37. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  38. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  39. Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed
  40. Denk D, et al. 2022. Immunity. 55:2059. PubMed
  41. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  42. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  43. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  44. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  45. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  46. Tello‐Lafoz M, et al. 2017. Sci Rep. . 10.1038/s41598-017-16370-w. PubMed
  47. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  48. Lechuga-Vieco AV, et al. 2020. Sci Adv. 6:eaba5345. PubMed
  49. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  50. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  51. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  52. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  53. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  54. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  55. Mei S, et al. 2022. Front Immunol. 13:911164. PubMed
  56. Ma F, et al. 2020. Cell Death Dis. 1.172222222. PubMed
  57. Baram T, et al. 2021. Cells. 10:. PubMed
  58. Leier A, et al. 2022. Mol Ther Nucleic Acids. 28:261. PubMed
  59. Andreas N, et al. 2021. Arthritis Res Ther. 23:222. PubMed
  60. Alotaibi F, et al. 2021. Front Immunol. 11:584937. PubMed
  61. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  62. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
  63. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  64. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  65. Wu FTH, et al. 2019. Br J Cancer. 120:196. PubMed
  66. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  67. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  68. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  69. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  70. Saito S, et al. 2020. Nutrients. 12:. PubMed
  71. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  72. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  73. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  74. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  75. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  76. Hung PJ, et al. 2018. Mol Cell. 71:332. PubMed
  77. Neubert K, et al. 2014. J Immunol. 192:5830. PubMed
  78. Sakthivel P, et al. 2014. PLoS One. 9:100970. PubMed
  79. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  80. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  81. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  82. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  83. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  84. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  85. Guo HF, et al. 2021. Commun Biol. 4:482. PubMed
  86. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  87. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  88. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  89. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  90. Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
  91. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  92. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  93. Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed
  94. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  95. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  96. Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed
  97. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  98. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  99. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  100. Wei M, et al. 2014. Protein Eng Des Sel. 27:289. PubMed
  101. Collinson-Pautz M, et al. 2016. PLoS One. 11:e0164547. PubMed
  102. Amor C, et al. 2020. Nature. 583:127. PubMed
  103. Dumas AA, et al. 2020. EMBO J. 39:e103790. PubMed
  104. Szafran BN, et al. 2021. Chemical Research in Toxicology. 34(6):1556-1571. PubMed
  105. Li J, et al. 2020. Cancer Discov. . PubMed
  106. Wei SC, et al. 2020. Cancer Discov. . PubMed
  107. Alsaleh G, et al. 2020. Elife. 9: . PubMed
  108. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  109. Daniel CJ, et al. 2022. Mol Cancer Res. 20:1151. PubMed
  110. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  111. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  112. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  113. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  114. Dar HY, et al. 2018. Sci Rep. 8:2503. PubMed
  115. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
  116. Li J, et al. 2020. Cancer Immunol Res. 0.529166667. PubMed
  117. Köchl R, et al. 2020. Elife. 9:00. PubMed
  118. Sullivan B, et al. 2015. PLoS Pathog. 11:1004588. PubMed
  119. Taniguchi H, et al. 2022. Cell Rep. 39:110814. PubMed
  120. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  121. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  122. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  123. Dar HY, et al. 2018. Bone Rep. 8:46. PubMed
  124. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  125. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  126. Li J, et al. 2018. Immunity. 49:178. PubMed
  127. Domingo–Gonzalez R, et al. 2020. eLife. 9:e56890.. PubMed
  128. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  129. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  130. Gong Y, et al. 2020. Cell Metabolism. 33(1):51-64.e9. PubMed
  131. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
  132. Pinho S, et al. 2022. Nat Cell Biol. 24:290. PubMed
  133. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  134. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  135. Reese B, et al. 2020. J Immunol. 205:3218. PubMed
  136. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  137. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  138. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  139. Sapra L, et al. 2021. Sci Rep. 11:1807. PubMed
  140. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  141. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  142. Yang Y, et al. 2022. Elife. 11:. PubMed
  143. Kim S, et al. 2021. Elife. 10:. PubMed
  144. Anger-Góra N, et al. 2021. Oncol Lett. 22:582. PubMed
  145. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  146. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  147. Pietronigro E, et al. 2019. Sci Rep. 9:12055. PubMed
  148. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  149. Abramowski P, et al. 2014. J Neuroimmunol. 274:111. PubMed
  150. Ariyoshi Y, et al. 2016. Gene Ther. 10.1038/gt.2016.7. PubMed
  151. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  152. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  153. Tan X, et al. 2021. Sci Adv. 7: . PubMed
  154. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  155. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  156. Lang V, et al. 2021. Elife. 10:. PubMed
  157. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  158. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  159. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  160. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  161. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  162. Yabas M, et al. 2016. PLoS One. 11: 0146774. PubMed
  163. Timilshina M, et al. 2017. PLoS One. 10.1371/journal.pone.0168942. PubMed
  164. Jandke A, et al. 2020. Nat Commun. 3.075694444. PubMed
  165. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  166. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  167. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  168. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  169. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
  170. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  171. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
  172. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  173. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  174. Nelson CE et al. 2019. Cell Rep. 28(12):3092-3104 . PubMed
  175. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  176. Niderla-Bielinska J, et al. 2021. Int J Mol Sci. :22. PubMed
  177. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  178. Itoga M, et al. 2015. PLoS One. 10: e0123210. PubMed
  179. Bhatt D, et al. 2021. J Exp Med. 218:. PubMed
  180. Wang D, et al. 2022. EMBO Rep. 23:e53691. PubMed
  181. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  182. Kojima H, et al. 2021. Scand J Immunol. 93:e13020. PubMed
  183. Emily A Thompson et al. 2019. Cell reports. 26(11):2859-2867 . PubMed
  184. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  185. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  186. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
  187. Ligon MM, et al. 2020. Mucosal Immunol. 1.172222222. PubMed
  188. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  189. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  190. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  191. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  192. Bell CR, et al. 2022. Nat Commun. 13:2063. PubMed
  193. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
  194. Silva DA, et al. 2019. Nature. 565:186. PubMed
  195. Lee YS, et al. 2019. Sci Adv. 5:eaaw4176. PubMed
  196. Abdelsamed HA, et al. 2020. Nat Immunol. 1.276388889. PubMed
  197. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  198. Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
  199. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  200. Rouse MD, et al. 2020. Front Microbiol. 11:414. PubMed
  201. Lopes N, et al. 2022. Elife. 11:. PubMed
  202. Tang S, et al. 2022. Virol J. 19:32. PubMed
  203. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  204. Fitzpatrick Z, et al. 2020. Nature. 587:472. PubMed
  205. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
  206. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  207. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  208. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  209. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  210. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  211. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  212. Wang X, et al. 2022. Elife. 11:. PubMed
  213. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  214. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  215. Ding Z, et al. 2017. Sci Rep. 10.1038/s41598-017-12488-z. PubMed
  216. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  217. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  218. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  219. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  220. Sheng J, et al. 2021. eLife. 10:00. PubMed
  221. Mykkänen O, et al. 2014. PLoS One. 9:114790. PubMed
  222. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  223. Goubet AG, et al. 2021. Cell Death Differ. 28:2276. PubMed
  224. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  225. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  226. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  227. Goc J, et al. 2021. Cell. 184:5015. PubMed
  228. Plaza-Sirvent C, et al. 2021. Front Immunol. 12:705436. PubMed
  229. Fearon AE, et al. 2021. iScience. 24:103143. PubMed
  230. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  231. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  232. Kim SH, et al. 2020. Neoplasia. 1.3375. PubMed
  233. Reinke S, et al. 2020. Cell Reports. 30(8):2501-2511. PubMed
  234. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  235. Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
  236. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  237. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  238. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  239. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  240. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
  241. Vick SC, et al. 2021. J Immunol. 207:2598. PubMed
  242. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  243. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  244. Schnell A, et al. 2021. Cell. 184:6281. PubMed
  245. Fu A, et al. 2022. Cell. 185:1356. PubMed
  246. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  247. Guttman O, et al. 2022. J Cell Biol. 221: . PubMed
  248. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  249. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  250. Gao Y, et al. 2022. Cell Res. 32:1086. PubMed
  251. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  252. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  253. Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed
  254. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  255. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  256. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  257. Wang C, et al. 2023. Exp Mol Med. 55:347. PubMed
  258. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  259. Georgiev GI, et al. 2022. Cell Chem Biol. 29:811. PubMed
  260. Zhu Z, et al. 2022. Clin Cancer Res. 28:4820. PubMed
  261. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  262. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  263. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  264. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  265. Schönberger K, et al. 2023. Anal Chem. 95:4325. PubMed
  266. Li L, et al. 2023. iScience. 26:106095. PubMed
  267. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  268. Cheng K, et al. 2023. Small. 19:e2300125. PubMed
  269. Li G, et al. 2023. Cell Death Dis. 14:185. PubMed
  270. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  271. Wang Y, et al. 2023. Front Bioeng Biotechnol. 11:1128268. PubMed
  272. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  273. Sun R, et al. 2023. PLoS One. 18:e0282722. PubMed
  274. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  275. Jarick KJ, et al. 2018. Front Immunol. 9:1468. PubMed
  276. Seo JB, et al. 2019. Nat Metab. 1:86. PubMed
  277. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  278. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  279. Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed
  280. Denk D, et al. 2022. Immunity. 55:2059. PubMed
  281. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  282. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  283. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  284. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  285. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  286. Tello‐Lafoz M, et al. 2017. Sci Rep. . 10.1038/s41598-017-16370-w. PubMed
  287. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  288. Lechuga-Vieco AV, et al. 2020. Sci Adv. 6:eaba5345. PubMed
  289. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  290. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  291. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  292. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  293. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  294. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  295. Mei S, et al. 2022. Front Immunol. 13:911164. PubMed
  296. Ma F, et al. 2020. Cell Death Dis. 1.172222222. PubMed
  297. Baram T, et al. 2021. Cells. 10:. PubMed
  298. Leier A, et al. 2022. Mol Ther Nucleic Acids. 28:261. PubMed
  299. Andreas N, et al. 2021. Arthritis Res Ther. 23:222. PubMed
  300. Alotaibi F, et al. 2021. Front Immunol. 11:584937. PubMed
  301. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  302. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
  303. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  304. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  305. Wu FTH, et al. 2019. Br J Cancer. 120:196. PubMed
  306. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  307. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  308. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  309. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  310. Saito S, et al. 2020. Nutrients. 12:. PubMed
  311. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  312. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  313. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  314. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  315. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  316. Hung PJ, et al. 2018. Mol Cell. 71:332. PubMed
  317. Neubert K, et al. 2014. J Immunol. 192:5830. PubMed
  318. Sakthivel P, et al. 2014. PLoS One. 9:100970. PubMed
  319. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  320. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  321. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  322. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  323. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  324. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  325. Guo HF, et al. 2021. Commun Biol. 4:482. PubMed
  326. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  327. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  328. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  329. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  330. Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
  331. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  332. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  333. Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed
  334. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  335. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  336. Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed
  337. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  338. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  339. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  340. Wei M, et al. 2014. Protein Eng Des Sel. 27:289. PubMed
  341. Collinson-Pautz M, et al. 2016. PLoS One. 11:e0164547. PubMed
  342. Amor C, et al. 2020. Nature. 583:127. PubMed
  343. Dumas AA, et al. 2020. EMBO J. 39:e103790. PubMed
  344. Szafran BN, et al. 2021. Chemical Research in Toxicology. 34(6):1556-1571. PubMed
  345. Li J, et al. 2020. Cancer Discov. . PubMed
  346. Wei SC, et al. 2020. Cancer Discov. . PubMed
  347. Alsaleh G, et al. 2020. Elife. 9: . PubMed
  348. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  349. Daniel CJ, et al. 2022. Mol Cancer Res. 20:1151. PubMed
  350. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  351. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  352. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  353. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  354. Dar HY, et al. 2018. Sci Rep. 8:2503. PubMed
  355. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
  356. Li J, et al. 2020. Cancer Immunol Res. 0.529166667. PubMed
  357. Köchl R, et al. 2020. Elife. 9:00. PubMed
  358. Sullivan B, et al. 2015. PLoS Pathog. 11:1004588. PubMed
  359. Taniguchi H, et al. 2022. Cell Rep. 39:110814. PubMed
  360. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  361. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  362. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  363. Dar HY, et al. 2018. Bone Rep. 8:46. PubMed
  364. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  365. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  366. Li J, et al. 2018. Immunity. 49:178. PubMed
  367. Domingo–Gonzalez R, et al. 2020. eLife. 9:e56890.. PubMed
  368. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  369. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  370. Gong Y, et al. 2020. Cell Metabolism. 33(1):51-64.e9. PubMed
  371. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
  372. Pinho S, et al. 2022. Nat Cell Biol. 24:290. PubMed
  373. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  374. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  375. Reese B, et al. 2020. J Immunol. 205:3218. PubMed
  376. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  377. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  378. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  379. Sapra L, et al. 2021. Sci Rep. 11:1807. PubMed
  380. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  381. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  382. Yang Y, et al. 2022. Elife. 11:. PubMed
  383. Kim S, et al. 2021. Elife. 10:. PubMed
  384. Anger-Góra N, et al. 2021. Oncol Lett. 22:582. PubMed
  385. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  386. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  387. Pietronigro E, et al. 2019. Sci Rep. 9:12055. PubMed
  388. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  389. Abramowski P, et al. 2014. J Neuroimmunol. 274:111. PubMed
  390. Ariyoshi Y, et al. 2016. Gene Ther. 10.1038/gt.2016.7. PubMed
  391. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  392. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  393. Tan X, et al. 2021. Sci Adv. 7: . PubMed
  394. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  395. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  396. Lang V, et al. 2021. Elife. 10:. PubMed
  397. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  398. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  399. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  400. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  401. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  402. Yabas M, et al. 2016. PLoS One. 11: 0146774. PubMed
  403. Timilshina M, et al. 2017. PLoS One. 10.1371/journal.pone.0168942. PubMed
  404. Jandke A, et al. 2020. Nat Commun. 3.075694444. PubMed
  405. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  406. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  407. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  408. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  409. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
  410. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  411. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
  412. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  413. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  414. Nelson CE et al. 2019. Cell Rep. 28(12):3092-3104 . PubMed
  415. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  416. Niderla-Bielinska J, et al. 2021. Int J Mol Sci. :22. PubMed
  417. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  418. Itoga M, et al. 2015. PLoS One. 10: e0123210. PubMed
  419. Bhatt D, et al. 2021. J Exp Med. 218:. PubMed
  420. Wang D, et al. 2022. EMBO Rep. 23:e53691. PubMed
  421. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  422. Kojima H, et al. 2021. Scand J Immunol. 93:e13020. PubMed
  423. Emily A Thompson et al. 2019. Cell reports. 26(11):2859-2867 . PubMed
  424. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  425. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  426. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
  427. Ligon MM, et al. 2020. Mucosal Immunol. 1.172222222. PubMed
  428. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  429. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  430. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  431. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  432. Bell CR, et al. 2022. Nat Commun. 13:2063. PubMed
  433. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
  434. Silva DA, et al. 2019. Nature. 565:186. PubMed
  435. Lee YS, et al. 2019. Sci Adv. 5:eaaw4176. PubMed
  436. Abdelsamed HA, et al. 2020. Nat Immunol. 1.276388889. PubMed
  437. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  438. Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
  439. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  440. Rouse MD, et al. 2020. Front Microbiol. 11:414. PubMed
  441. Lopes N, et al. 2022. Elife. 11:. PubMed
  442. Tang S, et al. 2022. Virol J. 19:32. PubMed
  443. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  444. Fitzpatrick Z, et al. 2020. Nature. 587:472. PubMed
  445. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
  446. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  447. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  448. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  449. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  450. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  451. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  452. Wang X, et al. 2022. Elife. 11:. PubMed
  453. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  454. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  455. Ding Z, et al. 2017. Sci Rep. 10.1038/s41598-017-12488-z. PubMed
  456. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  457. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  458. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  459. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  460. Sheng J, et al. 2021. eLife. 10:00. PubMed
  461. Mykkänen O, et al. 2014. PLoS One. 9:114790. PubMed
  462. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  463. Goubet AG, et al. 2021. Cell Death Differ. 28:2276. PubMed
  464. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  465. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  466. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  467. Goc J, et al. 2021. Cell. 184:5015. PubMed
  468. Plaza-Sirvent C, et al. 2021. Front Immunol. 12:705436. PubMed
  469. Fearon AE, et al. 2021. iScience. 24:103143. PubMed
  470. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  471. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  472. Kim SH, et al. 2020. Neoplasia. 1.3375. PubMed
  473. Reinke S, et al. 2020. Cell Reports. 30(8):2501-2511. PubMed
  474. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  475. Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
  476. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  477. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  478. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  479. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  480. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
RRID
AB_312761 (BioLegend Cat. No. 100722)
AB_312760 (BioLegend Cat. No. 100721)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC,IHC
FITC anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC-F,IP
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC,3D IHC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC,IHC,SB
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC,IP,Depletion,Block
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F,FC,3D IHC
Spark Blue™ 574 anti-mouse CD8a Antibody 53-6.7 FC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Spark UV™ 387 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 515 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark Red™ 718 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
PE/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark PLUS UV395™ anti-mouse CD8a 53-6.7 FC
PerCP/Fire™ 780 anti-mouse CD8a 53-6.7 FC
Spark YG™ 581 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
Spark YG™ 593 anti-mouse CD8a (Flexi-Fluor™) Antibody 53-6.7 FC
StarBright UltraViolet 575 anti-mouse CD8a 53-6.7 FC
Spark PLUS V475™ anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 795 anti-mouse CD8a 53-6.7 FC
Go To Top Version: 2    Revision Date: 01-21-2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account